DeepMed Research

Fujian Medical University Union Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website: http://www.fjxiehe.com/

Clinical Trials

Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy

Not Applicable

Conditions: Breast Cancer
Neoadjuvant Therapy
Sentinel Lymph Node Biopsy

Interventions: Drug: carbon dye

First Posted Date: 2022-08-23

Last Posted Date: 2022-08-23

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 200

Registration Number: NCT05512468

Locations: 🇨🇳
Study Officials, Fuzhou, Fujian, China

Efficacy and Safety of Astragalus for Non-motor Symptoms of α-Synucleinopathy

Phase 2

Recruiting

Conditions: Parkinsonism

Interventions: Behavioral: Physical therapy group
Drug: Astragalus

First Posted Date: 2022-08-18

Last Posted Date: 2023-09-13

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 40

Registration Number: NCT05506891

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Optimization of Glucocorticoid Taper Strategies for SLE-ITP

Not Applicable

Conditions: Lupus Erythematosus, Systemic
Purpura, Thrombocytopenic, Idiopathic
Glucocorticoids
Adverse Effect of Glucocorticoids

Interventions: Procedure: rapid GCs taper

First Posted Date: 2022-08-18

Last Posted Date: 2022-08-25

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 120

Registration Number: NCT05506033

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Dalpiciclib Plus Letrozole and Capecitabine

Phase 2

Conditions: Advanced Breast Cancer

Interventions: Drug: Dalpiciclib+ letrozole +capecitabine

First Posted Date: 2022-07-22

Last Posted Date: 2022-07-22

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 48

Registration Number: NCT05469750

Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database

Completed

Conditions: Adenocarcinoma of the Esophagogastric Junction

First Posted Date: 2022-06-15

Last Posted Date: 2022-11-04

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 1819

Registration Number: NCT05419349

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer

Phase 2

Recruiting

Conditions: Adjuvant Therapy
Breast Cancer

Interventions: Drug: Trastuzumab+Pertuzumab/Trastuzumab
Drug: Pyrotinib+Trastuzumab+Capecitabine

First Posted Date: 2022-03-23

Last Posted Date: 2022-03-23

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 206

Registration Number: NCT05292742

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer

Phase 2

Not yet recruiting

Conditions: Advanced Breast Cancer

Interventions: Drug: pyrotinib

First Posted Date: 2022-02-24

Last Posted Date: 2022-02-24

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 60

Registration Number: NCT05255523

Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.

Phase 1

Recruiting

Conditions: Esophageal Neoplasm
Radiotherapy
Immunotherapy

Interventions: Drug: Camrelizumab

First Posted Date: 2022-01-04

Last Posted Date: 2022-01-04

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 26

Registration Number: NCT05176002

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

Recruiting

Conditions: Radiation Oncology
Rectal Cancer

Interventions: Radiation: split-course HFRT
Drug: CAPOX chemotherapy
Drug: Tislelizumab

First Posted Date: 2022-01-04

Last Posted Date: 2023-09-25

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 50

Registration Number: NCT05176964

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Safety and Feasibility of the Application of Thoracic Puncture Tube After Pulmonary Lobectomy

Not Applicable

Conditions: Chest Tubes
Minimally Invasive Surgery
Pneumonectomy

Interventions: Procedure: thoracic drainage management

First Posted Date: 2021-01-22

Last Posted Date: 2021-05-11

Lead Sponsor: Fujian Medical University Union Hospital

Target Recruit Count: 100

Registration Number: NCT04718272

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy